242 related articles for article (PubMed ID: 34840688)
1. Intravitreal Methotrexate.
Abdi F; Mohammadi SS; Falavarjani KG
J Ophthalmic Vis Res; 2021; 16(4):657-669. PubMed ID: 34840688
[TBL] [Abstract][Full Text] [Related]
2. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
3. The role of methotrexate in resolving ocular inflammation after specific therapy for presumed latent syphilitic uveitis and presumed tuberculosis-related uveitis.
Sahin O; Ziaei A
Retina; 2014 Jul; 34(7):1451-9. PubMed ID: 24531737
[TBL] [Abstract][Full Text] [Related]
4. High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma.
Akiyama H; Takase H; Kubo F; Miki T; Yamamoto M; Tomita M; Mochizuki M; Miura O; Arai A
Cancer Sci; 2016 Oct; 107(10):1458-1464. PubMed ID: 27412324
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month study.
Razzaghpour N; Najafi A; Sabouri MR; Ashoori N; Shahraki K
Med Hypothesis Discov Innov Ophthalmol; 2023; 12(3):150-156. PubMed ID: 38476576
[TBL] [Abstract][Full Text] [Related]
6. Intraocular methotrexate can induce extended remission in some patients in noninfectious uveitis.
Taylor SR; Banker A; Schlaen A; Couto C; Matthe E; Joshi L; Menezo V; Nguyen E; Tomkins-Netzer O; Bar A; Morarji J; McCluskey P; Lightman S
Retina; 2013; 33(10):2149-54. PubMed ID: 23615343
[TBL] [Abstract][Full Text] [Related]
7. Intraocular Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy: A Review.
McAllister MA; Moore SM; Bullock B; Christoforidis JB
J Vitreoretin Dis; 2023; 7(2):144-153. PubMed ID: 37006665
[TBL] [Abstract][Full Text] [Related]
8. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
Zhou N; Xu X; Liu Y; Wang Y; Wei W
Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
[TBL] [Abstract][Full Text] [Related]
9. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravitreal methotrexate and aqueous humor cytokine levels in refractory retinal vasculitis in Behcet disease.
Bae JH; Lee SC
Retina; 2012 Jul; 32(7):1395-402. PubMed ID: 22012204
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month follow-up study.
Falavarjani KG; Golabi S; Modarres M
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2159-2164. PubMed ID: 27145784
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.
Anthony CL; Bavinger JC; Shantha JG; O'Keefe GD; Pearce WA; Voloschin A; Grossniklaus HE; Yeh S
Int J Retina Vitreous; 2021 Dec; 7(1):72. PubMed ID: 34863313
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of intravitreal methotrexate to salvage eyes with relapsed primary intraocular lymphoma.
Mohammad M; Andrews RM; Plowman PN; Hay G; Arora AK; Cohen VML; Sagoo MS
Br J Ophthalmol; 2022 Jan; 106(1):135-140. PubMed ID: 33087316
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Jonas JB; Kreissig I; Degenring RF
Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
[TBL] [Abstract][Full Text] [Related]
16. Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review.
Zehden JA; Mortensen XM; Reddy A; Zhang AY
Curr Diab Rep; 2022 Oct; 22(10):525-536. PubMed ID: 36053385
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
18. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
[TBL] [Abstract][Full Text] [Related]
19. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK
J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
